CCM Therapy for Heart Failure_Enduring Material
Cardiac contractility modulation (CCM) therapy is a new innovation in the treatment of symptomatic chronic heart failure patients who have a reduced left ventricular ejection fraction, who are in normal sinus rhythm and not candidates for cardiac resynchronization therapy. This therapy has been shown to reduce symptoms and improve quality of life while reducing the risk of hospitalization from decompensated heart failure. In this video conference, we will discuss the benefits of CCM therapy, the mechanism of action by which this therapy improves clinical outcomes, indications, and implantation technique. We will discuss the evidence that supports the use of this therapy in chronic heart failure.
Practicing cardiologists, cardiovascular disease fellows, cardiovascular advanced practice providers, electrophysiologists, heart failure specialists, heart failure nurses, pharmacists
Matthew Lander, MD
George Shaw, MD
Srinivas Murali, MD
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance